Recruiting

CAR-T Cell Therapy

Sponsor:

Lymphoma and Leukemia Society

Code:

NCT07173322

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.

Conditions

Cancer

Study ID

NCT07173322

Start date

Feb 9, 2025

Status verified date

Sep, 2025

Completion date

Feb 9, 2026

Anticipated

Primary completion date

Feb 9, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

  • any cancer patient
  • at least 18 years of age
  • with a history of receiving CAR-T Cell treatment.

less than 18 years old.

\-

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • The Impact of CAR-T Cell Therapy on Fertility [ Time Frame: data will be collected for 1 year ]

Central Contacts and Locations

Central contacts

Janaela Scott

844-696-7228 (24 hours)Janaela.Scott@lls.org

Brian Chadwick, RN MS

9144145788chadwickbj@gmail.com

Locations

Internet

Recruiting

Rye, New York, United States, 10573

Contacts

Nina Logan, MD

914-821-8497Nina.Logan@lls.org

Janaela Scott

9148218497Janaela.Scott@lls.org

Principal Investigator:

Nina Logan, MD

More Information

Sponsor

Lymphoma and Leukemia Society

Last update posted

Sep 15, 2025

Last verified

Sep, 2025

Keywords

  • Cancer
  • CAR Tcell treatment

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Lymphoma and Leukemia Society on 2025-09-15.